HCA
NEO icon

Harbor Capital Advisors’s NeoGenomics NEO Stock Holding History

Harbor Capital Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27M Sell
223,846
-19,771
-8% -$191K 0.22% 110
2026
Q1 		$1.81M Buy
+243,617
New +$2.56M 0.15% 211

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Harbor Capital Advisors's NEO Position: Q2 2026 in Review

Harbor Capital Advisors reduced its NeoGenomics (NEO) stake by 8.1% in Q2 2026, selling an estimated $191K and leaving 223,846 shares worth $3.27M. The position accounts for 0.22% of the portfolio, ranked #110.

Harbor Capital Advisors first reported a position in NEO in Q1 2026 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Harbor Capital Advisors held 223,846 shares of NeoGenomics worth $3.27M as of Q2 2026.
  • Harbor Capital Advisors sold 19,771 NeoGenomics shares in Q2 2026, an estimated $191K.
  • NeoGenomics made up 0.22% of Harbor Capital Advisors's portfolio in Q2 2026, its #110 holding.
  • Harbor Capital Advisors first reported a position in NeoGenomics in Q1 2026 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.